Descripción del título
Cytokines as Potential Ther...
Cytokines and cytokine receptors remain an area of great interest for the development of targeted therapies for cutaneous inflammatory diseases. Anti-TNF therapeutics have proven to be effective in the treatment of psoriasis, and clinical investigations have now begun for other cytokine-directed therapies, such as those targeting IFN-g, IL-12p40, and IL-18. In addition to therapeutics that target cytokines directly, strategies that target cytokine signaling pathways are in development. This book summarizes the findings of the 56th International Workshop of the Ernst Schering Research Foundation that focused on "Cytokines as Potential Therapeutic Targets for Inflammatory Skin Diseases"
Monografía
monografia Rebiun06121641 https://catalogo.rebiun.org/rebiun/record/Rebiun06121641 cr nn 008mamaa 100301s2006 gw | s |||| 0|eng d 9783540376736 UPVA 997151630703706 UAM 991007633190404211 UNAV 616.5 23 Numerof, R. Cytokines as Potential Therapeutic Targets for Inflammatory Skin Diseases Recurso electrónico] edited by R. Numerof, C. A. Dinarello, K. Asadullah Berlin, Heidelberg Springer Berlin Heidelberg 2006 Berlin, Heidelberg Berlin, Heidelberg Springer Berlin Heidelberg XVII, 209 p. 30 illus XVII, 209 p. 30 illus Ernst Schering Research Foundation Workshop 56 Springer eBooks Inhibition of IFN-y as a Method of Treatment of Various Autoimmune Diseases, Including Skin Diseases -- Cytokine Targeting in Psoriasis and Psoriatic Arthritis: Beyond TNFa -- Inhibitors of Histone Deacetylases as Anti-Inflammatory Drugs -- Dendritic Cells Interactions and Cytokine Production -- Lysomal Cysteine Proteases and Antigen Presentation -- DCs and Cytokines Cooperate for the Induction of Tregs -- Induction of Immunity and Inflammation by Interleukin-12 Family Members -- The Role of TNFa and IL-17 in the Development of Excess IL-1 Signaling-Induced Inflammatory Diseases in IL-1 Receptor Antagonist-Deficient Mice -- TGF- Mediated Immunoregulation -- TNF-Blockade: An Inflammatory Issue -- Il-1 Family Members in Inflammatory Skin Disease Cytokines and cytokine receptors remain an area of great interest for the development of targeted therapies for cutaneous inflammatory diseases. Anti-TNF therapeutics have proven to be effective in the treatment of psoriasis, and clinical investigations have now begun for other cytokine-directed therapies, such as those targeting IFN-g, IL-12p40, and IL-18. In addition to therapeutics that target cytokines directly, strategies that target cytokine signaling pathways are in development. This book summarizes the findings of the 56th International Workshop of the Ernst Schering Research Foundation that focused on "Cytokines as Potential Therapeutic Targets for Inflammatory Skin Diseases" Forma de acceso: World Wide Web Dinarello, C. A. Asadullah, K. SpringerLink